Login

Journal Front Page

News & Events

  • Call for article for January 2025 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 4 (October 2024 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

PHARMACOLOGICAL MANAGEMENT OF TYPE II DIABETES MELLITUS: REVIEW

Jagpreet Kaur Sandhu, Saurabh Sharma*, Rupali Bharti Sao, Smruti Ranjan Dash

Faculty of Pharmacy, Kalinga University, Naya Raipur, Chhattisgarh India (492101)

ABSTRACT

Diabetes Mellitus is a non-communicable disease caused due to hyperglycaemia. It possesses threat to millions of people worldwide and is the cause of morbidity and early mortality in individuals. Studies have shown links between diabetes mellitus and other comorbidities such as cardiovascular disorders, hypertension and renal disorders. Cognitive decline, functional disability and infections also follows. Insulin resistance has a direct metabolic effect on heart. Insulin sensitisers have a beneficial vascular effect. Nutritional therapy, weight management and appropriate class of medications should be provided to control these diseases. This review summarises the increasing risk of Diabetes Mellitus and the emerging complications due to it. How non communicable diseases in India are reaching an epidemic position. They can be reversed by taking appropriate measures and lifestyle changes and the with the advancement in medical technology treatment is possible to delay the effects of these diseases. However, it is important to realise that lifestyle modification as a therapeutic measure should be reinforced by the government and medical professionals as apart of educating the masses.

Keywords: Diabetes, hypertension, dyslipidemia, obesity.


[Full Text Article]